Hepatocellular Carcinoma Drugs are prescribed for cancer patients to minimize side-effects of chemotherapy and kill cancer cells
Hepatocellular carcinoma is one of the most prevalent types of cancer in the world and is one of the most common cancers worldwide. Furthermore, the increased intake of paracetamol and aflatoxin has led to the emergence of novel treatments. The newly developed hepatocellular carcinoma drugs aim to meet the unmet medical needs of people with hepatocellular carcinoma. However, the new drugs have been accompanied by several side effects, including anemia, pneumonia, and low white blood cell counts. Although there are some risks associated with the treatment of HCC, noticeable improvements in patients' health should offset these concerns in the future. According to the " Coherent Market Insights " Global Industry Insights, Trends, Outlook, and Opportunity Analysis of Hepatocellular Carcinoma Drugs Market . Hepatocellular Carcinoma Drugs Market The main molecular targets of hepatocellular carcinoma drugs include transforming growth factor-b (TGF-b), TGF-b receptors, and ep...